Use of Radiomics to Predict Response to Immunotherapy of Malignant Tumors of the Digestive System.

CONCLUSIONS Radiomics can predict the response of patients with malignant tumors of the digestive system to immunotherapy and can supplement conventional evaluations of response. PMID: 33077705 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research